Bicalutamide ('Casodex') 150mg in addition to standard care in patients with nonmetastatic prostate cancer: Updated results from a randomised double-blind phase III study (median follow-up 5.1y) in the early prostate cancer programme
- Wirth, M.
- Tyrrell, C.
- Delaere, K.
- Sánchez-Chapado, M.
- Ramon, J.
- Wallace, D.M.A.
- Hetherington, J.
- Pina, F.
- Heyns, C.
- Borchers, T.
- Morris, T.
- Armstrong, J.
ISSN: 1365-7852, 1476-5608
Year of publication: 2005
Volume: 8
Issue: 2
Pages: 194-200
Type: Article